Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating an alternative schedule of Velcade (bortezomib), dexamethasone, and liposomal doxorubicin (Doxil) in multiple myelo…
-
CLINICAL_TRIALS trial_result · 2012-03-21Clinical Trial Update: Health-Related Quality of Life (QOL), Physical and Respiratory Function in Patients With Myeloma Affecting the Spine
This document reports the completed clinical trial evaluating health-related quality of life, physical function, and respiratory function in…
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation [NA]
This clinical trial update reports on a study evaluating CD8+ T cell depletion as prophylaxis against graft-versus-host disease after periph…
-
CLINICAL_TRIALS trial_result · 2012-03-14Clinical Trial Update: A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma [Phase 3]
A multicenter, single-arm, open-label safety study evaluating lenalidomide plus dexamethasone in patients with previously treated multiple m…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: T-Cell-Depleted Allogeneic Stem Cell Transplantation After Immunoablative Induction Chemotherapy and Reduced-Intensity Transplantation Conditioning in Treating Patients With Hematologic Malignancies [Phase 1]
Phase 1 trial assessing T-cell-depleted allogeneic stem cell transplantation after immunoablative induction chemotherapy and reduced-intensi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma [Phase 2]
Phase 2 study evaluating Velcade (bortezomib) with Doxil (liposomal doxorubicin) and dexamethasone as first-line therapy for multiple myelom…
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma [NA]
Clinical trial update indicating the study evaluating Velcade (bortezomib), Doxil (liposomal doxorubicin), and dexamethasone (VDd) in multip…
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions [Phase 4]
A Phase 4 clinical trial evaluating zoledronic acid in patients with breast cancer, multiple myeloma, and prostate cancer with cancer-relate…
-
CLINICAL_TRIALS trial_result · 2012-01-23Clinical Trial Update: A Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor (Ruxolitinib; INBC018424) in Patients With Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating the safety and effect of the JAK2 inhibitor ruxolitinib in patients with multiple myeloma has completed wi…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: A Study of Bevacizumab in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (AMBER) [Phase 2]
A Phase 2 trial evaluating the combination of bevacizumab with bortezomib in relapsed or refractory multiple myeloma has completed enrollmen…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating a busulfan plus melphalan conditioning regimen for lymphoid malignancies and multiple myeloma; the study c…
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma [Phase 3]
Phase 3 trial comparing Velcade (bortezomib) to high-dose dexamethasone in relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039 [Phase 3]
Phase 3 trial of PS-341 (bortezomib) in patients with multiple myeloma who progressed after dexamethasone has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-29Clinical Trial Update: Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Velcade (bortezomib) in combination with other drugs for previously untreated multiple myeloma has compl…
-
CLINICAL_TRIALS trial_result · 2011-12-26Clinical Trial Update: Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 trial evaluating sorafenib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma has terminated with results p…
-
CLINICAL_TRIALS trial_result · 2011-12-19Clinical Trial Update: Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies [Phase 1]
This update covers a Phase 1 trial of anti-third-party donor T lymphocytes with nonmyeloablative stem cell transplantation for indolent lymp…
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer [Phase 2]
A Phase 2 trial evaluating zoledronic acid (Zometa) retention and effects in patients with multiple myeloma and breast cancer.
-
CLINICAL_TRIALS trial_result · 2011-12-05Clinical Trial Update: Intravenous rhMBL in Patients With Multiple Myeloma Receiving Chemotherapy Followed by Stem Cell Transplant [Phase 1]
Phase 1 trial evaluating intravenous rhMBL in patients with multiple myeloma receiving chemotherapy and stem cell transplant has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-02Clinical Trial Update: Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7) [Phase 3]
Phase 3 trial evaluating peginterferon alfa-2b as maintenance therapy in multiple myeloma patients who responded to induction therapy; the s…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
This Phase 2 clinical trial update reports on bone marrow transplantation as a treatment for hematologic cancers, including leukemia, lympho…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Antithymocyte Globulin in Treating Patients Undergoing Stem Cell Transplant for Multiple Myeloma [Phase 2]
Phase 2 trial evaluating antithymocyte globulin (Thymoglobulin) in patients undergoing stem cell transplantation for multiple myeloma has co…
-
CLINICAL_TRIALS trial_result · 2011-11-30Clinical Trial Update: Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation [Phase 2]
This clinical trial update reports results from a Phase 2 study of lymphocyte infusion for patients who relapsed cancer after bone marrow or…
-
CLINICAL_TRIALS trial_result · 2011-11-17Clinical Trial Update: Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma [Phase 2]
Phase 2 trial evaluating a conditioning regimen of total-body irradiation, busulfan, and interferon alfa before peripheral stem cell or bone…
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma [Phase 3]
A multicenter, single-arm expanded-access study of lenalidomide plus dexamethasone in previously treated multiple myeloma, with results post…
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: The Effect of High Dose Simvastatine on Multiple Myeloma [Phase 1, Phase 2]
This update notes the completion of a Phase 1/Phase 2 clinical trial assessing high-dose simvastatin in multiple myeloma. The study evaluate…